Neurogene Inc. (NGNE) Stock Grade

About Neurogene Inc.'s fundamentals

Neurogene Inc. is a biotechnology company with a market capitalization of $450.1 million that reported zero revenue in its latest annual period, representing a complete decline from the prior year. The company posted a net loss, resulting in a net margin of 0.0%, and does not pay a dividend. Traditional valuation metrics like P/E ratio and return on equity are not applicable given the company's current financial position as a pre-revenue or early-stage biotech firm.